BioCentury
ARTICLE | Financial News

Delenex completes venture financing

November 15, 2010 8:00 AM UTC

Delenex Therapeutics AG, Zurich, Switzerland Business: Antibodies, Autoimmune Date completed: 11/12/10 Type: Venture financing Raised: CHF13.5 million ($14 million) Investors: SV Life Sciences; HBM Bi...